OTTRIA, ROBERTA
OTTRIA, ROBERTA
Dipartimento di Scienze Biomediche e Cliniche
Oral administration of plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signaling
2024 D. Cervia, S. Zecchini, L. Pincigher, P. Roux-Biejat, C. Zalambani, E. Catalani, A. Arcari, S. Del Quondam, K. Brunetti, R. Ottria, S. Casati, C. Vanetti, M.C. Barbalace, C. Prata, M. Malaguti, S.R. Casati, L. Lociuro, M. Giovarelli, E. Mocciaro, S. Falcone, C. Fenizia, C. Moscheni, S. Hrelia, C. De Palma, E. Clementi, C. Perrotta
Tracing zinc’s role in preterm infants’ health: A narrative review
2024 A. Consales, C. Agostoni, R. Cazzola, R. Ottria, M.L. Giannì
Pre- to Postbiotics: The Beneficial Roles of Pediatric Dysbiosis Associated with Inflammatory Bowel Diseases
2024 R. Ottria, O. Xynomilakis, S. Casati, P. Ciuffreda
Placental Bioenergetics and Antioxidant Homeostasis in Maternal Obesity and Gestational Diabetes
2024 C. Mando, S. Castiglioni, C. Novielli, G.M. Anelli, A. Serati, F. Parisi, C. Lubrano, M. Zocchi, R. Ottria, M. Giovarelli
Lipids and lipid signaling molecules in human milk and infant formula, a chemical characterization of relevant biochemical components
2024 R. Ottria, M.D. Porta, O. Xynomilakis, S. Casati, R. Cazzola, P. Ciuffreda
Fluorescence-Based Enzyme Activity Assay: Ascertaining the Activity and Inhibition of Endocannabinoid Hydrolytic Enzymes
2024 P. Ciuffreda, O. Xynomilakis, S. Casati, R. Ottria
Chios Mastic Gum: Chemical Profile and Pharmacological Properties in Inflammatory Bowel Disease: From the Past to the Future
2023 R. Ottria, O. Xynomilakis, S. Casati, E. Abbiati, G. Maconi, P. Ciuffreda
2-Arachidonoylglycerol Synthesis: Facile and Handy Enzymatic Method That Allows to Avoid Isomerization
2022 R. Ottria, S. Casati, P. Rota, P. Ciuffreda
Small-Molecules as Chemiluminescent Probes to Detect Lipase Activity
2022 P. LA ROCCA, A. Mingione, S.M. Casati, R. Ottria, P. Allevi, P. Ciuffreda, P. Rota
A New Ultrasensitive Bioluminescence-Based Method for Assaying Monoacylglycerol Lipase
2021 M. Miceli, S. Casati, P. Allevi, S. Berra, R. Ottria, P. Rota, B.R. Branchini, P. Ciuffreda
Clarifying the Use of Benzylidene Protecting Group for D-($mathplus$)-Ribono-1,4-Lactone, an Essential Building Block in the Synthesis of C-Nucleosides
2021 S.M. Casati, P. Rota, P. Allevi, A. Mingione, R. Ottria, P. Ciuffreda
Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model
2020 F. Andreata, A. Bonizzi, M. Sevieri, M. Truffi, M. Monieri, L. Sitia, F. Silva, L. Sorrentino, R. Allevi, P. Zerbi, B. Marchini, E. Longhi, R. Ottria, S. Casati, R. Vanna, C. Morasso, M. Bellini, D. Prosperi, F. Corsi, S. Mazzucchelli
Quantitative Lipidomic Analysis of Osteosarcoma Cell-Derived Products by {UHPLC}-{MS}/{MS}
2020 S. Casati, C. Giannasi, M. Minoli, S. Niada, A. Ravelli, I. Angeli, V. Mergenthaler, R. Ottria, P. Ciuffreda, M. Orioli, A.T. Brini
Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage
2020 R. Vago, A. Ravelli, A. Bettiga, S. Casati, G. Lavorgna, F. Benigni, A. Salonia, F. Montorsi, M. Orioli, P. Ciuffreda, R. Ottria
Simple Synthesis of 17-β-O-hemisuccinate of Stanozolol for Immunoanalytical Methods
2020 S. Casati, R. Ottria, P. Ciuffreda
Lipid peroxidation inhibition study: A promising case of 1,3-di([1,1′-biphenyl]-3-yl)urea
2020 J. Lazarević, A. Šmelcerović, J. Zvezdanović, D. Yancheva, S. Casati, R. Ottria, P. Ciuffreda
Quantitative Characterization of Olaparib in Nanodelivery System and Target Cell Compartments by LC-MS/MS
2019 R. Ottria, A. Ravelli, M. Miceli, S. Casati, M. Orioli, P. Ciuffreda
Set-up and validation of a high throughput screening method for human monoacylglycerol lipase (MAGL) based on a new red fluorescent probe
2019 M. Miceli, S. Casati, R. Ottria, S. Di Leo, I. Eberini, L. Palazzolo, C. Parravicini, P. Ciuffreda
Everolimus Nanoformulation in Biological Nanoparticles Increases Drug Responsiveness in Resistant and Low-Responsive Breast Cancer Cell Lines
2019 A. Bonizzi, M. Truffi, M. Sevieri, R. Allevi, L. Sitia, R. Ottria, L. Sorrentino, C. Sottani, S. Negri, E. Grignani, S. Mazzucchelli, F. Corsi
Olaparib nanoformulation in H-ferritin as a promising option for both BRCA-mutated and sporadic triple negative breast cancer: An in vitro study
2018 S. Mazzucchelli, M. Truffi, L. Sorrentino, M. Bellini, M. Rizzuto, R. Ottria, P. Ciuffreda, D. Prosperi, F. Corsi